Overexpression of bone sialoprotein leads to an uncoupling of bone formation and bone resorption in mice.
The purpose of this study was to determine the effects of bone sialoprotein (BSP) overexpression in bone metabolism in vivo by using a homozygous transgenic mouse line that constitutively overexpresses mouse BSP cDNA driven by the cytomegalovirus (CMV) promoter. CMV-BSP transgenic (TG) mice and wildtype mice were weighed, and their length, BMD, and trabecular bone volume were measured. Serum levels of RANKL, osteocalcin, osteoprotegerin (OPG), TRACP5b, and PTH were determined. Bone histomorphometry, von Kossa staining, RT-PCR analysis, Western blot, MTS assay, in vitro mineralization assay, and TRACP staining were also performed to delineate phenotypes of this transgenic mouse line. Compared with wildtype mice, adult TG mice exhibit mild dwarfism, lower values of BMD, and lower trabecular bone volume. TG mice serum contained increased calcium levels and decreased PTH levels, whereas the levels of phosphorus and magnesium were within normal limits. TG mice serum also exhibited lower levels of osteoblast differentiation markers and higher levels of markers, indicating osteoclastic activity and bone resorption. H&E staining, TRACP staining, and bone histomorphometry showed that adult TG bones were thinner and the number of giant osteoclasts in TG mice was higher, whereas there were no significant alterations in osteoblast numbers between TG mice and WT mice. Furthermore, the vertical length of the hypertrophic zone in TG mice was slightly enlarged. Moreover, ex vivo experiments indicated that overexpression of BSP decreased osteoblast population and increased osteoclastic activity. Partly because of its effects in enhancing osteoclastic activity and decreasing osteoblast population, BSP overexpression leads to an uncoupling of bone formation and resorption, which in turn results in osteopenia and mild dwarfism in mice. These findings are expected to help the development of therapies to metabolic bone diseases characterized by high serum level of BSP.
Valverde
Paloma
P
Division of Oral Biology, Department of General Dentistry, Tufts University School of Dental Medicine, Boston, Massachusetts 02111, USA.
Zhang
Jin
J
Fix
Amanda
A
Zhu
Ji
J
Ma
Wenli
W
Tu
Qisheng
Q
Chen
Jake
J
D000135:Acid Phosphatase / Q000378:metabolism; D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D015519:Bone Density; D001862:Bone Resorption / Q000378:metabolism* / Q000503:physiopathology; D001842:Bone and Bones / Q000033:anatomy & histology; D002113:Calcification, Physiologic; D002454:Cell Differentiation; D002478:Cells, Cultured; D003587:Cytomegalovirus; D015536:Down-Regulation; D004392:Dwarfism / Q000378:metabolism; D005260:Female; D006720:Homozygote; D058574:Integrin-Binding Sialoprotein; D007527:Isoenzymes / Q000378:metabolism; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D009929:Organ Size; D010006:Osteoblasts / Q000166:cytology / Q000378:metabolism; D010010:Osteoclasts / Q000166:cytology / Q000378:metabolism; D010012:Osteogenesis; D012795:Sialoglycoproteins / Q000378:metabolism*; D012886:Skull / Q000166:cytology; D000071681:Tartrate-Resistant Acid Phosphatase; D015854:Up-Regulation
D015415:Biomarkers; C546872:Ibsp protein, mouse; D058574:Integrin-Binding Sialoprotein; D007527:Isoenzymes; D012795:Sialoglycoproteins; D000135:Acid Phosphatase; D000071681:Tartrate-Resistant Acid Phosphatase